Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiangdong Qiu

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Cancer Letters|November 28, 2022
mTOR inhibitor, gemcitabine and PD-L1 antibody blockade combination therapy suppresses pancreatic cancer progression via metabolic reprogramming and immune microenvironment remodeling in Trp53<sup>flox/+</sup>LSL-Kras<sup>G12D/+</sup>Pdx-1-Cre murine modelsJiangdong Qiu, Mengyu Feng, Gang Yang, et al.
Journal of Robotic Surgery|December 7, 2025
Is Kangduo robotic distal pancreatectomy more economically efficient and effective in postoperative outcomes compared to laparoscopic surgery? A propensity-matched analysisWenhao Luo, Guihu Weng, Zhe Cao, et al.
Cancer Biology & Medicine|September 18, 2020
MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapyZhe Cao, Jiangdong Qiu, Gang Yang, et al.
Cancer Letters|August 20, 2023
Organoid: Bridging the gap between basic research and clinical practiceGuihu Weng, Jinxin Tao, Yueze Liu, et al.
Molecular Cancer|January 7, 2018
Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applicationsJiangdong Qiu, Gang Yang, Mengyu Feng, et al.
Frontiers in Oncology|November 7, 2022
Cancer-specific survival and metastasis in pancreatic mucinous cystadenocarcinoma: A SEER-based cohort studyRuobing Wang, Dan Su, Yueze Liu, et al.
Heliyon|July 24, 2023
PRKRA promotes pancreatic cancer progression by upregulating MMP1 transcription via the NF-κB pathwayJiangdong Qiu, Mengyu Feng, Gang Yang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 14, 2018
LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancerMengyu Feng, Guangbing Xiong, Zhe Cao, et al.
Frontiers in Cell and Developmental Biology|January 28, 2022
Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic CancerGuangyu Chen, Junyu Long, Ruizhe Zhu, et al.
Cancer Letters|August 9, 2025
Organoids in the research of pancreatic neoplasms: cultivation, applications, and limitationsChangwei Du, Yueze Liu, Xiaoyue Lu, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Cancer Letters|November 28, 2022
mTOR inhibitor, gemcitabine and PD-L1 antibody blockade combination therapy suppresses pancreatic cancer progression via metabolic reprogramming and immune microenvironment remodeling in Trp53<sup>flox/+</sup>LSL-Kras<sup>G12D/+</sup>Pdx-1-Cre murine modelsJiangdong Qiu, Mengyu Feng, Gang Yang, et al.
Journal of Robotic Surgery|December 7, 2025
Is Kangduo robotic distal pancreatectomy more economically efficient and effective in postoperative outcomes compared to laparoscopic surgery? A propensity-matched analysisWenhao Luo, Guihu Weng, Zhe Cao, et al.
Cancer Biology & Medicine|September 18, 2020
MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapyZhe Cao, Jiangdong Qiu, Gang Yang, et al.
Cancer Letters|August 20, 2023
Organoid: Bridging the gap between basic research and clinical practiceGuihu Weng, Jinxin Tao, Yueze Liu, et al.
Molecular Cancer|January 7, 2018
Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applicationsJiangdong Qiu, Gang Yang, Mengyu Feng, et al.
Frontiers in Oncology|November 7, 2022
Cancer-specific survival and metastasis in pancreatic mucinous cystadenocarcinoma: A SEER-based cohort studyRuobing Wang, Dan Su, Yueze Liu, et al.
Heliyon|July 24, 2023
PRKRA promotes pancreatic cancer progression by upregulating MMP1 transcription via the NF-κB pathwayJiangdong Qiu, Mengyu Feng, Gang Yang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 14, 2018
LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancerMengyu Feng, Guangbing Xiong, Zhe Cao, et al.
Frontiers in Cell and Developmental Biology|January 28, 2022
Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic CancerGuangyu Chen, Junyu Long, Ruizhe Zhu, et al.
Cancer Letters|August 9, 2025
Organoids in the research of pancreatic neoplasms: cultivation, applications, and limitationsChangwei Du, Yueze Liu, Xiaoyue Lu, et al.
Pageof 6